Collegium Pharmaceutical, Inc.
NasdaqGS:COLL
$ 32.47
$0.00 (0.00%)
$ 32.47
$0.00 (0.00%)
End-of-day quote: 05/18/2024

Collegium Pharmaceutical financials at a glance

The revenue of Collegium Pharmaceutical is reported as 0.56677 billion Dollars in the fiscal year 2023. The earnings were 5.47 Dollars per share in 2023, which was 38.13 higher than 2022. And about 0.27429 billion Dollars are reported as free cash flow in the financials of Collegium Pharmaceutical 2023. No dividends were paid to the shareholders of the Collegium Pharmaceutical stock NasdaqGS:COLL in the financial year 2023.

$566.77M
Revenue
$5.47
Earnings Per Share
85.93%
Gross Margin %
$278.53M
Free Cash Flow
Revenue
566.77
Earnings Per Share
5.47
Gross Margin %
85.93
Free Cash Flow
278.53

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015
Rev. Revenue N/A $566.77M $463.93M $276.87M $310.02M $296.70M $280.41M $28.48M $1.71M $0.00M
GM % Gross Margin % 77.97% 85.93% 74.52% 78.66% 77.58% 39.70% 80.09% 90.89% 87.55% 0.00%
OM Operating Margin 15.67% 33.63% 7.18% 9.08% 18.14% -8.00% -7.38% -,258.47% 0.00% 0.00%
EPS Earnings Per Share $0.25 $5.47 $3.96 $4.15 $3.79 $0.26 $-0.86 $-2.47 $-3.88 $-1.48
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0 0 0 0 0 0 0 0 0
Sha. Shares N/AM 31.96M 34.07M 33.38M 34.76M 34.05M 33.31M 32.99M 29.45M 23.51M
OCF Operating Cash Flow N/A $274.75M $124.23M $103.56M $93.94M $27.78M $169.39M $-67.02M $-75.05M $-21.57M
FCF Free Cash Flow N/A $278.53M $122.61M $101.62M $88.39M $21.35M $163.91M $-68.01M $-75.53M $-21.93M
FCFS Free Cash Flow Per Share $7.82 $8.13 $3.62 $2.91 $-8.13 $0.64 $4.40 $-2.25 $-3.22 $-1.62